SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001418812-17-000025
Filing Date
2017-03-16
Accepted
2017-03-16 16:42:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D vrx13d031617.txt SC 13D 37836
  Complete submission text file 0001418812-17-000025.txt   39595
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45947 | Film No.: 17695115
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, 4TH FLOOR SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, 4TH FLOOR SAN FRANCISCO CA 94129 415-362-3700
VA Partners I, LLC (Filed by) CIK: 0001418812 (see all company filings)

IRS No.: 421745536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D